Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹17,159Accepted-Finance | ₹17,159 | L1 | Accepted-Finance rate approved as per proceeding of negitation vide letter no 5325-26 dated 31.08.2026 |
| 2 | L1₹17,159Accepted-Finance | ₹17,159 | L1 | Accepted-Finance rate approved as per proceeding of negitation vide letter no 5325-26 dated 31.08.2026 |
| 3 | L1₹17,159Accepted-Finance | ₹17,159 | L1 | Accepted-Finance rate approved as per proceeding of negitation vide letter no 5325-26 dated 31.08.2026 |
| 4 | L1₹17,159Accepted-Finance 324 3RD FLOOR ANGEL MEGA MALL PLOT NO CK 1 KAUSHAMBHI GHAZIABAD UTTAR PRADESH 201010 | GHAZIABAD | UTTAR PRADESH | 201010 | ₹17,159 | L1 | Accepted-Finance rate approved as per proceeding of negitation vide letter no 5325-26 dated 31.08.2026 |
| 5 | L1₹17,159Accepted-Finance | ₹17,159 | L1 | Accepted-Finance rate approved as per proceeding of negitation vide letter no 5325-26 dated 31.08.2026 |
| Sl No | Description | Qty | Unit | Poly Medicure Ltd. L1 | Envision Scientific Private Limited L3 | HARI OM TRADERS L2 | EVAA MEDICARE L7 | Nikkon Biotech Medical Agency L9 | Zydus Medtech Pvt Ltd L4 | INNVOLUTION HEALTHCARE PRIVATE LIMITED L5 | SANGAM AGENCIES L6 | REMEDIAL LIFESCIENCES L8 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | SirolimusDrugelutingstainlesssteelstentsUSFDAapproved | 1 | Nos | - | - | - | - | - | - | - | - | - |
| 2.00 | SirolimusDrugelutingstainlesssteelstentsCEapproved | 1 | Nos | - | - | - | - | - | - | - | - | - |
| 3.00 | SirolimusDrugelutingstainlesssteelstentsDCGIapproved | 1 | Nos | - | - | - | - | - | - | - | - | - |
| 4.00 | SirolimusDrugelutingCobaltchromiumstentsUSFDAapproved | 1 | Nos | - | - | - | - | - | - | - | - | - |
| 5.00 | SirolimusDrugelutingCobaltchromiumstentsCEapproved | 1 | Nos | - | 28,500 ₹28,500 | - | 22,500 ₹22,500 Lowest | - | 27,500 ₹27,500 | - | - | 22,500 ₹22,500 Lowest |
| 6.00 | SirolimusDrugelutingCobaltchromiumstentsDCGIapproved | 1 | Nos | 22,485 ₹22,485 | 21,500 ₹21,500 | 27,500 ₹27,500 | - | - | 27,500 ₹27,500 | - | 22,040 ₹22,040 | 19,000 ₹19,000 Lowest |
| 7.00 | Sirolimus Drug eluting Cobalt chromium stent with pasive coating of amorphous silicon carbideandactivecoatingofbiodegradable drug matrixconsistingofsirolimusandpolymer poly-l-lactide polymer | 1 | Nos | - | - | - | - | 39,186 ₹39,186 Lowest | - | - | - | - |
| 8.00 | Sirolimus Drug eluting Cobalt chromium hybrid double helix stents with thicness < 60 µm with pasive coating of amorphous silicon carbide and active coating of biodegradable drug matrix consisting of sirolimus and polymer poly-l-lactide polymer | 1 | Nos | - | - | - | - | 39,186 ₹39,186 Lowest | - | - | - | - |
| 9.00 | Sirolimus Drug eluting Cobalt chromium stent with biodegradable polymer , microporous surface, shellac resin, abluminal coating | 1 | Nos | - | - | - | - | - | - | - | - | 39,186 ₹39,186 Lowest |
| 10.00 | Sirolimus Drug eluting Cobaltchromiumstent withdualdrugpolymerfree microporous surface, abluminal coating | 1 | Nos | - | - | - | - | - | - | - | - | - |
Tender Value
Refer Docs
EMD Value
₹2 L
Closing Date
20 Jul 2026, 1:00 pmClosed
MS cum Member Secretary DRPGMC Tanda
MS cum Member Secretary DRPGMC Tanda
please refer to tender documents
2026_DMER5_137568_1
E-Tender of Cardiology Implants Stent
Open Tender
Consumables (Hospital / Lab)
Item Wise
M S Office DRPGMC Tanda
please refer to tender documents
3 documents required · 3 mandatory
₹5,000
MS DRPGMC Tanda
₹2 L
18 Sept 2026
27 Jun 2026
20 Jul 2026
30 Jun 2026
20 Jul 2026
4 Jul 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | SirolimusDrugelutingstainlesssteelstentsUSFDAapproved | 1 | Nos | - | - |
| 2 | SirolimusDrugelutingstainlesssteelstentsCEapproved | 1 | Nos | - | - |
| 3 | SirolimusDrugelutingstainlesssteelstentsDCGIapproved | 1 | Nos | - | - |
| 4 | SirolimusDrugelutingCobaltchromiumstentsUSFDAapproved | 1 | Nos | - | - |
| 5 | SirolimusDrugelutingCobaltchromiumstentsCEapproved | 1 | Nos | - | - |
| 6 | SirolimusDrugelutingCobaltchromiumstentsDCGIapproved | 1 | Nos | - | - |
| 7 | Sirolimus Drug eluting Cobalt chromium stent with pasive coating of amorphous silicon carbideandactivecoatingofbiodegradable drug matrixconsistingofsirolimusandpolymer poly-l-lactide polymer | 1 | Nos | - | - |
| 8 | Sirolimus Drug eluting Cobalt chromium hybrid double helix stents with thicness < 60 µm with pasive coating of amorphous silicon carbide and active coating of biodegradable drug matrix consisting of sirolimus and polymer poly-l-lactide polymer | 1 | Nos | - | - |
| 9 | Sirolimus Drug eluting Cobalt chromium stent with biodegradable polymer , microporous surface, shellac resin, abluminal coating | 1 | Nos | - | - |
| 10 | Sirolimus Drug eluting Cobaltchromiumstent withdualdrugpolymerfree microporous surface, abluminal coating | 1 | Nos | - | - |
stage.html
html • 0.06 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.69 MB
termsandconditions.pdf
Tender Documents • 8.39 MB
BOQ_203625.xls
BOQ • 0.51 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .